Intestinal fluid transport regulation

Intestinal fluid transport regulation is a complex physiological process rather than a single molecular target, involving the coordinated activity of multiple transporters, channels, and signaling pathways to maintain water and electrolyte homeostasis in the gut (PubMed: 28847668). The primary drivers of this process include the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR), which facilitates chloride secretion, and the Sodium-Hydrogen Exchanger 3 (NHE3), which mediates sodium absorption (NIH: NBK560708). A key regulatory node is the Guanylate cyclase C (GC-C) receptor; its activation by endogenous ligands or drugs like linaclotide increases intracellular cGMP, which simultaneously stimulates CFTR-mediated secretion and inhibits NHE3-mediated absorption, resulting in net fluid secretion into the intestinal lumen (PubMed: 24514371). Dysregulation of these mechanisms leads to clinical conditions such as secretory diarrhea, often triggered by bacterial toxins, or chronic constipation when the secretory drive is insufficient. Therapeutic intervention typically involves targeting specific components of this regulatory network, such as using GC-C agonists or NHE3 inhibitors to treat constipation and IBS, or CFTR inhibitors and opioid agonists to manage diarrhea.

Other names

Intestinal fluid homeostasisIntestinal electrolyte transportIntestinal water transportGastrointestinal fluid secretion and absorption

Guanylate cyclase C (GC-C) agonism; Sodium-hydrogen exchanger 3 (NHE3) inhibition; Chloride channel activation (ClC-2); CFTR inhibition; Opioid receptor agonism; Enkephalinase inhibition